October 11th, 2012 by Staff
GlaxoSmithKline announced today, 10/11/2012, that they will make all clinical trial data available to researchers in their effort to become a more transparent company. This move could have a positive effect on clinical oncology practice.
August 19th, 2011 by Jay Bitkower, ACKC president and survivor
Dr. Janice Dutcher has moved her clinical practice and IL-2 treatment program from the Montefiore Medical Center in the Bronx to the St. Luke’s Roosevelt Hospital Center in Manhattan where Dr. Dutcher is the Director of the Immunotherapy Program.
August 16th, 2011 by Staff
Stanford University researchers have discovered a molecule that directly attacks kidney cancer cells that have the VHL tumor-suppressor gene mutated or disabled. VHL deficient genes are present in 85-90% of clear cell carcinoma, the most prevalent type of kidney cancer.
January 25th, 2011 by Staff
ACKC announced the launch of a new website and online community to raise awareness of kidney cancer with the goal of raising funds for kidney cancer research and educating Congress about the need for more research funding.
September 25th, 2010 by Staff
The International Kidney Cancer Coalition (IKCC) hosted its first Annual Conference, “Expanding Circles,” which took place from September 10-13, 2010 in Frankfurt, Germany.